Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients

Xiaoning Wu, Xiaoqian Xu, Jialing Zhou, Yameng Sun, Huiguo Ding, Wen Xie, Guofeng Chen, Anlin Ma, HongXin Piao, Bingqiong Wang, Shuyan Chen, Tongtong Meng, Xiaojuan Ou, Hwai-I Yang, Jidong Jia, Yuanyuan Kong, Hong You

Clin Mol Hepatol. 2023;29(3):747-762. Published online May 10, 2023

DOI: https://doi.org/10.3350/cmh.2023.0121

View: 2333 Download: 129 Crossref: 1

Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly

Young Eun Chon, Seong Yong Park, Han Pyo Hong, Donghee Son, Jonghyun Lee, Eileen Yoon, Soon Sun Kim, Sang Bong Ahn, Soung Won Jeong, Dae Won Jun

Clin Mol Hepatol. 2023;29(1):120-134. Published online August 12, 2022

DOI: https://doi.org/10.3350/cmh.2021.0395

View: 4284 Download: 196 Web of Science: 17 Crossref: 17

Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods

Seung Mi Lee, Suhyun Hwangbo, Errol R. Norwitz, Ja Nam Koo, Ig Hwan Oh, Eun Saem Choi, Young Mi Jung, Sun Min Kim, Byoung Jae Kim, Sang Youn Kim, Gyoung Min Kim, Won Kim, Sae Kyung Joo, Sue Shin, Chan-Wook Park, Taesung Park, Joong Shin Park

Clin Mol Hepatol. 2022;28(1):105-116. Published online October 15, 2021

DOI: https://doi.org/10.3350/cmh.2021.0174

View: 6565 Download: 197 Web of Science: 6 Crossref: 7

Editorial

Transient elastography can be integrated into routine clinical practice for the evaluation of portal hypertension?

Beom Kyung Kim

Clin Mol Hepatol. 2017;23(1):27-30. Published online March 24, 2017

DOI: https://doi.org/10.3350/cmh.2017.0101

View: 6938 Download: 112 Web of Science: 3 Crossref: 3

3

Establishment of Individual Prediction Model According to Risk Factorsfor Development of Hepatocellular Carcinoma in Korea : Establishment of Individual Prediction Model for Hepatocellular Carcinoma

Jae Youn Cheong, M.D., Kwang-Hyub Han, M.D., Dong Kee Kim, Ph.D.*, Sang Hoon Ahn, M.D., Ki Jun Song, M.S.*, Yong Han Paik, M.D., Chang Hwan Choi, M.D., Hyun Woong Lee, M.D., Young Soo Park, M.D., Chae Yoon Chon, M.D., and Young Myoung Moon, M.D.,

Clin Mol Hepatol. 2001;7(4):449-458. Published online January 1, 1970

View: 2192 Download: 18

1 |

Viewed By 5415	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5387	MAFLD: How is it different from NAFLD?
Viewed By 5274	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3940	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3930	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 77	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search